Stockscreener 앱 받기
50.16
2.07%
-1.06
시간 외 거래:
50.16
전일 마감가:
$51.22
열려 있는:
$51.43
하루 거래량:
48,187
Relative Volume:
1.12
시가총액:
$N/A
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-3.91%
1개월 성능:
+5.16%
6개월 성능:
+63.71%
1년 성능:
+50.51%
1일 변동 폭
$49.80
$51.43
1주일 범위
$49.80
$51.91
52주 변동 폭
$22.33
$52.90
Alps Medical Breakthroughs Etf Stock (SBIO) Company Profile
SBIO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SBIO
Alps Medical Breakthroughs Etf
|
50.16 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
336.31 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
683.17 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
686.19 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
261.54 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
613.12 | 124.43B | 0 | 0 | 0 | 0.00 |
Alps Medical Breakthroughs Etf 주식(SBIO)의 최신 뉴스
How ALPS Medical Breakthroughs ETF stock correlates with oil marketsVolatility Trading Techniques & Big Gains Low Cost - bollywoodhelpline.com
ALPS Medical Breakthroughs ETF $SBIO Shares Sold by DAVENPORT & Co LLC - Defense World
ALPS ETFs in Biotech and Commodities Lead 2025 Gains - ETF Database
The Technical Signals Behind (SBIO) That Institutions Follow - Stock Traders Daily
ALPS Medical Breakthroughs ETF declares annual distribution of $0.0000 - MSN
Can ALPS Medical Breakthroughs ETF stock reach $200 price targetJuly 2025 Review & Fast Gain Stock Trading Tips - Улправда
Why millennials buy ALPS Medical Breakthroughs ETF stock2025 Technical Patterns & Weekly Breakout Stock Alerts - Улправда
Recap Report: How ALPS Medical Breakthroughs ETF stock correlates with oil marketsMarket Performance Recap & Technical Confirmation Alerts - Улправда
Biotech ETF SBIO Hovers Near Peak on Rally - ETF Database
Precision Trading with Alps Medical Breakthroughs Etf (SBIO) Risk Zones - Stock Traders Daily
What hedge fund moves indicate for ALPS Medical Breakthroughs ETF stock2025 Major Catalysts & Fast Entry and Exit Trade Plans - Newser
Tema’s Oncology ETF (CANC) Surpasses $100m in Assets Amidst Strong 2025 Performance - PharmiWeb.com
Will ALPS Medical Breakthroughs ETF stock gain from green policiesGlobal Markets & Risk Controlled Daily Plans - Newser
Can ALPS Medical Breakthroughs ETF stock withstand sector downturnsJuly 2025 Movers & Low Drawdown Momentum Ideas - Newser
Is ALPS Medical Breakthroughs ETF stock a buy for dividend portfolios2025 Stock Rankings & AI Forecasted Stock Moves - Newser
Technical Reactions to SBIO Trends in Macro Strategies - Stock Traders Daily
SBIO: A Shock Biotech Winner In 2025 - Seeking Alpha
Anatomy of an AI Trade: How I Use AI to Make Money in Stocks - Money Talks News
Funds - Zacks Investment Research
Is ALPS Medical Breakthroughs ETF stock a buy during volatile marketsJuly 2025 Summary & Free Daily Entry Point Trade Alerts - newser.com
How higher bond yields impact ALPS Medical Breakthroughs ETF stockJuly 2025 Highlights & Free Low Drawdown Momentum Trade Ideas - newser.com
ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO) Shares Down 0.4% – Here’s What Happened - Defense World
Will ALPS Medical Breakthroughs ETF stock split increase liquidityGlobal Markets & Low Risk Growth Stock Ideas - newser.com
How ALPS Medical Breakthroughs ETF stock reacts to monetary easingSwing Trade & Weekly Hot Stock Watchlists - newser.com
Is ALPS Medical Breakthroughs ETF stock a momentum leaderWeekly Profit Report & Accurate Buy Signal Notifications - newser.com
Why ALPS Medical Breakthroughs ETF stock attracts HNW investorsShort Setup & Advanced Technical Analysis Signals - newser.com
Trading the Move, Not the Narrative: (SBIO) Edition - news.stocktradersdaily.com
Biotech Consolidation Could Perk Up, Lift This ETF - ETF Database
ETF Building Blocks Content Hub - ETF Database
Is ALPS Medical Breakthroughs ETF stock worth buying before Fed action2025 Big Picture & Entry and Exit Point Strategies - newser.com
Alps Medical Breakthroughs Etf (SBIO) 재무 분석
Alps Medical Breakthroughs Etf (SBIO)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.95%
0.34%
자본화:
|
볼륨(24시간):